Ocular Therapeutix CEO and CSO Sell Company Shares

Ocular Therapeutix Chief Executive Officer Jeffrey Dugel and Chief Scientific Officer Hans Heier have each sold a portion of their company shares. The transactions were reported following standard SEC filing requirements for corporate insiders.